Sarcopenia
Who is at risk?
- Average men and women over the age of 30 begin losing muscle at a rate of 15% per year.
-
Sedentary adults risk losing up to 30% of muscle by the age of 75.
Astaxanthin was shown to be an effective agent to enhance skeletal muscle performance and counteract the detrimental effects of skeletal muscle disuse. The mechanisms of action of astaxanthin may be attributed to its ability to prevent oxidative stress.
ValAsta neutralizes free radicals and prevents oxidative stress. The patented Valasta/astaxanthin is the most absorbable astaxanthin available.
ValAsta Reverses Sarcopenia by Fighting Free Radicals
